The private equity secondary market is booming, with volumes surpassing $160 billion last year. But according to Ricardo Miró-Quesada, Partner and Head of Private Equity at Arcano Capital, this is only the beginning—especially in Europe.
In a video interview with 0100 Conferences, Miró-Quesada highlighted Arcano’s focus on secondaries, driven by rising demand for liquidity and the growing use of GP-led transactions. With many post-2020 funds soon entering the market, he sees strong momentum ahead.
While the U.S. leads in volume, Europe’s share is expanding quickly. As transparency improves, secondaries are shifting from a liquidity fix to a strategic tool for institutional investors.
Arcano, with over €12 billion in AUM, is leveraging its deep market relationships to capitalize on what Miró-Quesada calls “just the tip of the iceberg” in the evolving secondaries landscape.
As private equity adapts to a prolonged high-cost environment, investors are being forced to rethink how they source deals, create value, and deploy capital. Ahead of her appearance at 0100 Europe (April 21–23), we spoke with Geraldine O’Keeffe, Partner at EQT Healthcare Growth, about how one of Europe’s leading investment platforms is transiting today’s market dynamics—across healthcare, technology, and beyond.
